ORBIMED ADVISORS LLC sold 3.7% of their position (281.41K shares) of ENLIVEN THERAPEUTICS, INC. on the open market
Open‑market sale worth $12.67M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/17/2026ACC: 0000947871-26-000637
Director10% Owner
Since Mar 2020
-281.41K
Net shares
Net seller
$12.67M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
281.41K disposed
Non-Derivative Transactions2
Common Stock
Indirect
Shares
−9.09K
Price / share
$45.02
Trade value
$409.05K
% of position
3.6%
6/15/2026
254.81K→245.73K
Common Stock
Indirect
Shares
−272.32K
Price / share
$45.02
Trade value
$12.26M
% of position
3.6%
6/15/2026
7.66M→7.39M
Total
Net shares
−281.41K
Net value
-$12.67M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/15/2026 | S · Sale | −9.09K | $45.02 | $409.05K | 3.6% | 254.81K | 245.73K |
| Common Stock Indirect | 6/15/2026 | S · Sale | −272.32K | $45.02 | $12.26M | 3.6% | 7.66M | 7.39M |
| Total | −281.41K | -$12.67M | ||||||
Derivative Transactions0
No derivative transactions reported